These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15226094

  • 1. Shear stress-dependent platelet function after LDL cholesterol apheresis.
    Spieker LE, Ruschitzka F, Badimon JJ, Noll G, Corti R.
    Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
    [Abstract] [Full Text] [Related]

  • 2. C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis.
    Spieker LE, Flammer AJ, Amacker N, Sudano I, Badimon JJ, Ruschitzka F, Lüscher TF, Noll G, Corti R.
    Thromb Haemost; 2006 Oct; 96(4):540-2. PubMed ID: 17003936
    [No Abstract] [Full Text] [Related]

  • 3. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F, Jaeger BR, Oberhoffer M, Reichart B, Seidel D.
    Z Kardiol; 2003 Oct; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [Abstract] [Full Text] [Related]

  • 4. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D.
    Z Kardiol; 2003 Oct; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [Abstract] [Full Text] [Related]

  • 5. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D, Mellwig KP.
    Z Kardiol; 2003 Oct; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
    Wendler T, Schilling R, Lennertz A, Sodemann K, Kleophas W, Messner H, Riechers G, Wagner J, Keller C, Bosch T.
    J Clin Apher; 2003 Oct; 18(4):157-66. PubMed ID: 14699591
    [Abstract] [Full Text] [Related]

  • 7. Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia.
    Igarashi K, Tsuji M, Nishimura M, Horimoto M.
    J Clin Apher; 2004 Oct; 19(1):11-6. PubMed ID: 15095396
    [Abstract] [Full Text] [Related]

  • 8. [Effects of LDL-apheresis--more than reduction of cholesterol?].
    Schettler V, Wieland E.
    Dtsch Med Wochenschr; 2007 Mar 16; 132(11):575-8. PubMed ID: 17342636
    [Abstract] [Full Text] [Related]

  • 9. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
    Pusl T, Broedl UC, Parhofer KG, Otto C.
    Clin Hemorheol Microcirc; 2009 Mar 16; 41(2):137-42. PubMed ID: 19252236
    [Abstract] [Full Text] [Related]

  • 10. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
    Jaeger BR, Bengel FM, Odaka K, Uberfuhr P, Labarrere CA, Bengsch S, Engelschalk C, Kreuzer E, Reichart B, Schwaiger M, Seidel D.
    J Heart Lung Transplant; 2005 Dec 16; 24(12):2022-30. PubMed ID: 16364844
    [Abstract] [Full Text] [Related]

  • 11. One year experience with a low density lipoprotein apheresis system.
    Durst R, Rund D, Schurr D, Eliav O, Ben-Yehuda D, Shpizen S, Ben-Avi L, Schaap T, Pelz I, Leitersdorf E.
    Isr Med Assoc J; 2002 Sep 16; 4(9):677-80. PubMed ID: 12440228
    [Abstract] [Full Text] [Related]

  • 12. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T, Lennertz A, Schenzle D, Dräger J, Direct adsorption of lipoproteins (DALI) study group.
    J Clin Apher; 2002 Sep 16; 17(4):161-9. PubMed ID: 12494408
    [Abstract] [Full Text] [Related]

  • 13. [H.E.L.P. apheresis and oxidative stress].
    Pulawski E, Mellwig KP, Horstkotte D.
    Z Kardiol; 2003 Sep 16; 92(Suppl 3):III38-41. PubMed ID: 14663600
    [Abstract] [Full Text] [Related]

  • 14. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H, Shigematsu H, Ishimaru S, Iwai T, Akaba N, Umezu S.
    Int Angiol; 2006 Sep 16; 25(3):287-92. PubMed ID: 16878078
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
    Otto C, Berster J, Otto B, Parhofer KG.
    J Clin Apher; 2007 Sep 16; 22(6):301-5. PubMed ID: 17935245
    [Abstract] [Full Text] [Related]

  • 17. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC, Otto C, Parhofer KG.
    Metabolism; 2006 May 16; 55(5):599-604. PubMed ID: 16631435
    [Abstract] [Full Text] [Related]

  • 18. Comparison of different LDL apheresis methods.
    Julius U, Frind A, Tselmin S, Kopprasch S, Poberschin I, Siegert G.
    Expert Rev Cardiovasc Ther; 2008 Jun 16; 6(5):629-39. PubMed ID: 18510481
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.
    Bosch T, Thiery J, Gurland HJ, Seidel D.
    Nephrol Dial Transplant; 1993 Jun 16; 8(12):1350-8. PubMed ID: 8159304
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.